Manganese-induced toxicity in normal and human B lymphocyte cell lines containing a homozygous mutation in parkin

Toxicology in Vitro

Volumn 26, Issue 7, 2012, Pages 1143-1149

  Roth, Jerome A ^a   Ganapathy, Balakrishnan ^a   Ghio, Andrew J ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Apoptosis; Lymphocytes; Manganese; Manganism; Oxidative stress; Parkin; Parkinson's disease

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; MANGANESE; PARKIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL ACTIVITY; CELL FUNCTION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME SYNTHESIS; GENE MUTATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PROTEIN DEPLETION; PROTEIN FUNCTION;

ADENOSINE TRIPHOSPHATE; ADULT; APOPTOSIS; B-LYMPHOCYTES; CASPASE 3; CELL LINE, TRANSFORMED; CELL SURVIVAL; CHLORIDES; DOPAMINE; HUMANS; MALE; MANGANESE COMPOUNDS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MUTATION; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84866053350     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.07.005     Document Type: Article

References (46)

1. Aydemir T.B., Liuzzi J.P., McClellan S., Cousins R.J. Zinc transporter ZIP8 (SLC39A8) and zinc influence IFN-gamma expression in activated human T cells. J. Leukoc. Biol. 2009, 86:337-348.
2. Brouillet E.P., Shinobu L., McGarvey U., Hochberg F., Beal M.F. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp. Neurol. 1993, 120:89-94.
3. Chen C.J., Liao S.L. Oxidative stress involves in astrocytic alterations induced by manganese. Exp. Neurol. 2002, 175:216-225.
4. Chun H.S., Lee H., Son J.H. Manganese induces endoplasmic reticulum (ER) stress and activates multiple caspases in nigral dopaminergic neuronal cells, SN4741. Neurosci. Lett. 2001, 316:5-8.
5. Dev K.K., van der Putten H., Sommer B., Rovelli G. Part I: parkin-associated proteins and Parkinson's disease. Neuropharmacology 2003, 45:1-13.
6. El Mchichi B., Hadji A., Vazquez A., Leca G. P38 MAPK and MSK1 mediate caspase-8 activation in manganese-induced mitochondria-dependent cell death. Cell Death Differ. 2007, 14:1826-1836.
7. Galvani P., Fumagalli P., Santagostino A. Vulnerability of mitochondrial complex I in PC12 cells exposed to manganese. Eur. J. Pharmacol. 1995, 293:377-383.
8. Gavin C.E., Gunter K.K., Gunter T.E. Mn2+ sequestration by mitochondria and inhibition of oxidative phosphorylation. Toxicol. Appl. Pharmacol. 1992, 115:1-5.
9. Gavin C.E., Gunter K.K., Gunter T.E. Manganese and calcium transport in mitochondria: implications for manganese toxicity. Neurotoxicology 1999, 20:445-453.
10. Gitler A.D., Chesi A., Geddie M.L., Strathearn K.E., Hamamichi S., Hill K.J., Caldwell K.A., Caldwell G.A., Cooper A.A., Rochet J.C., Lindquist S. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 2009, 41:308-315.
11. Gorell J.M., Johnson C.C., Rybicki B.A., Peterson E.L., Kortsha G.X., Brown G.G., Richardson R.J. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 1999, 20:239-247.
12. Guilarte T.R., Burton N.C., McGlothan J.L., Verina T., Zhou Y., Alexander M., Pham L., Griswold M., Wong D.F., Syversen T., Schneider J.S. Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism. J. Neurochem. 2008, 107:1236-1247.
13. Gunter T.E., Gavin C.E., Gunter K.K. The case for manganese interaction with mitochondria. Neurotoxicology 2009, 30:727-729.
14. Higashi Y., Asanuma M., Miyazaki I., Hattori N., Mizuno Y., Ogawa N. Parkin attenuates manganese-induced dopaminergic cell death. J. Neurochem. 2004, 89:1490-1497.
15. Hilker R., Klein C., Ghaemi M., Kis B., Strotmann T., Ozelius L.J., Lenz O., Vieregge P., Herholz K., Heiss W.D., Pramstaller P.P. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol 2001, 49:367-376.
16. Hirata Y. Manganese-induced apoptosis in PC12 cells. Neurotoxicol. Teratol. 2002, 24:639-653.
17. Hudnell H.K. Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies. Neurotoxicology 1999, 20:379-397.
18. Huynh D.P., Scoles D.R., Nguyen D., Pulst S.M. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum. Mol. Genet. 2003, 12:2587-2597.
19. Hyun D.H., Lee M., Halliwell B., Jenner P. Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults. J. Neurosci. Res. 2005, 82:232-244.
20. Ikeuchi K., Marusawa H., Fujiwara M., Matsumoto Y., Endo Y., Watanabe T., Iwai A., Sakai Y., Takahashi R., Chiba T. Attenuation of proteolysis-mediated cyclin E regulation by alternatively spliced Parkin in human colorectal cancers. Int. J. Cancer 2009, 125:2029-2035.
21. Jiang H., Jiang Q., Liu W., Feng J. Parkin suppresses the expression of monoamine oxidases. J. Biol. Chem. 2006, 281:8591-8599.
22. Jimenez Del Rio M., Moreno S., Garcia-Ospina G., Buritica O., Uribe C.S., Lopera F., Velez-Pardo C. Autosomal recessive juvenile parkinsonism Cys212Tyr mutation in parkin renders lymphocytes susceptible to dopamine- and iron-mediated apoptosis. Mov. Disord. 2004, 19:324-330.
23. Kim Y., Kim J.M., Kim J.W., Yoo C.I., Lee C.R., Lee J.H., Kim H.K., Yang S.O., Chung H.K., Lee D.S., Jeon B. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?. Mov. Disord. 2002, 17:568-575.
24. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
25. Ko H.S., von Coelln R., Sriram S.R., Kim S.W., Chung K.K., Pletnikova O., Troncoso J., Johnson B., Saffary R., Goh E.L., Song H., Park B.J., Kim M.J., Kim S., Dawson V.L., Dawson T.M. Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J. Neurosci. 2005, 25:7968-7978.
26. Kuroda Y., Sako W., Goto S., Sawada T., Uchida D., Izumi Y., Takahashi T., Kagawa N., Matsumoto M., Takahashi R., Kaji R., Mitsui T. Parkin interacts with Klokin1 for mitochondrial import and maintenance of membrane potential 2011, Hum Mol Genet.
27. Lesage S., Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 2009, 18:R48-59.
28. Lim K.L., Chew K.C., Tan J.M., Wang C., Chung K.K., Zhang Y., Tanaka Y., Smith W., Engelender S., Ross C.A., Dawson V.L., Dawson T.M. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J. Neurosci. 2005, 25:2002-2009.
29. Lima P.D., Vasconcellos M.C., Bahia M.O., Montenegro R.C., Pessoa C.O., Costa-Lotufo L.V., Moraes M.O., Burbano R.R. Genotoxic and cytotoxic effects of manganese chloride in cultured human lymphocytes treated in different phases of cell cycle. Toxicol. In Vitro 2008, 22:1032-1037.
30. Mizuno Y., Hattori N., Mori H., Suzuki T., Tanaka K. Parkin and Parkinson's disease. Curr. Opin. Neurol. 2001, 14:477-482.
31. Oliveira S.A., Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Lyons K.E., Pahwa R., Stern M.B., Hiner B.C., Jankovic J., Ondo W.G., Allen F.H., Scott B.L., Goetz C.G., Small G.W., Mastaglia F.L., Stajich J.M., Zhang F., Booze M.W., Reaves J.A., Middleton L.T., Haines J.L., Pericak-Vance M.A., Vance J.M., Martin E.R. Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Arch. Neurol. 2003, 60:975-980.
32. Pacelli C., De Rasmo D., Signorile A., Grattagliano I., di Tullio G., D'Orazio A., Nico B., Comi G.P., Ronchi D., Ferranini E., Pirolo D., Seibel P., Schubert S., Gaballo A., Villani G., Cocco T. Mitochondrial defect and PGC-1alpha dysfunction in parkin-associated familial Parkinson's disease. Biochim. Biophys. Acta 2011, 1812:1041-1053.
33. Ren Y., Jiang H., Yang F., Nakaso K., Feng J. Parkin protects dopaminergic neurons against microtubule-depolymerizing toxins by attenuating microtubule-associated protein kinase activation. J. Biol. Chem. 2009, 284:4009-4017.
34. Ren Y., Zhao J., Feng J. Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation. J. Neurosci. 2003, 23:3316-3324.
35. Roth J.A. Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination. Biol. Res. 2006, 39:45-57.
36. Roth J.A. Are there common biochemical and molecular mechanisms controlling manganism and Parkisonism. NeuroMolec. Med. 2009, 11:281-296.
37. Roth J.A., Feng L., Walowitz J., Browne R.W. Manganese-induced rat pheochromocytoma (PC12) cell death is independent of caspase activation. J. Neurosci. Res. 2000, 61:162-171.
38. Roth J.A., Singleton S., Feng J., Garrick M., Paradkar P.N. Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1. J. Neurochem. 2010, 113:454-464.
39. Satoh J., Kuroda Y. Association of codon 167 Ser/Asn heterozygosity in the parkin gene with sporadic Parkinson's disease. NeuroReport 1999, 10:2735-2739.
40. Schrantz N., Blanchard D.A., Mitenne F., Auffredou M.T., Vazquez A., Leca G. Manganese induces apoptosis of human B cells: caspase-dependent cell death blocked by bcl-2. Cell Death Differ. 1999, 6:445-453.
41. Szargel R., Rott R., Engelender S. Synphilin-1 isoforms in Parkinson's disease: regulation by phosphorylation and ubiquitylation. Cell. Mol. Life Sci. 2008, 65:80-88.
42. Verina T., Kiihl S.F., Schneider J.S., Guilarte T.R. Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. Neurotoxicology 2011, 32:215-226.
43. West A.B., Maraganore D., Crook J., Lesnick T., Lockhart P.J., Wilkes K.M., Kapatos G., Hardy J.A., Farrer M.J. Functional association of the parkin gene promoter with idiopathic Parkinson's disease. Hum. Mol. Genet. 2002, 11:2787-2792.
44. Wider C., Wszolek Z.K. Clinical genetics of Parkinson's disease and related disorders. Parkinsonism Relat Disord 2007, 13(Suppl 3):S229-S232.
45. Yang Y.X., Wood N.W., Latchman D.S. Molecular basis of Parkinson's disease. NeuroReport 2009, 20:150-156.
46. Zhang S., Fu J., Zhou Z. Changes in the brain mitochondrial proteome of male Sprague-Dawley rats treated with manganese chloride. Toxicol. Appl. Pharmacol. 2005, 202:13-17.